| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_09db6b6eeace4e14c63d4d42bd14ac5d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a9e9ce63eb0bbf3658453fb50a6d9b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb9cde2fef92f0444d271578a274b98d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 |
| filingDate |
2012-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0854e4da2db4f8fff1369a0f4c6e081d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_827adc123d590ea745eed9cc25695a7e |
| publicationDate |
2012-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2012116089-A1 |
| titleOfInvention |
Benzimidazole derivative |
| abstract |
The invention relates to a process for preparing the compound of formula 1, a valuable intermediate product in the synthesis of the pharmaceutical active substance dabigatran etexilate. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8962574-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8993770-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9089488-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011118471-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8471033-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011123635-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011129538-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8399678-B2 |
| priorityDate |
2007-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |